UBX-0101

N/A

Report date: 2025/08/07 20:00:08
NME

Base Information

Drug NameUBX-0101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAscentage Pharma Group InternationalUnity Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnity Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A